M11.00
Hydroxyapatite deposition disease, unspecified site
Clinical Classification Guidelines
Medical Intelligence & Overview
Hydroxyapatite deposition disease (HADD) is a condition characterized by the abnormal build-up of hydroxyapatite crystals in soft tissues, particularly around joints. This can lead to inflammation, pain, and restricted movement in the affected area. Although the precise cause remains unclear, HADD most commonly affects tendons, bursae, and other soft tissue structures near joints. Diagnosing this condition involves imaging techniques, and treatment typically focuses on managing symptoms and reducing inflammation. Awareness of HADD is important for those experiencing unexplained joint discomfort, especially in middle-aged and older adults.
Causes & Symptoms
Clinical Causes: Unknown precise cause; thought to involve calcification of soft tissues. Degenerative changes in joints or tendons due to aging. Repetitive trauma or stress to the affected area. Metabolic or mineral imbalance affecting calcium and phosphate levels. Fibrotic changes in tendons or bursae that promote crystal deposition.
Key Symptoms: Localized pain around the affected joint or soft tissue area. Swelling, redness, or warmth in the region. Limited range of motion or stiffness of the joint. Tenderness to touch over the deposit site. Occasional reports of acute flare-ups with sudden increase in pain.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of HADD typically involves a combination of clinical examination and imaging techniques. Key diagnostic methods include:
Treatment Protocols: Management of hydroxyapatite deposition disease aims to relieve symptoms and reduce inflammation. Typical treatment approaches include:
Clinical Advice & FAQs
Billing Guidance
Is M11.00 a billable ICD-10 code?
Yes, M11.00 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.00?
Clinical documentation must specify the nature of Hydroxyapatite deposition disease, unspecified site and any associated comorbidities for accurate reporting.
Cite this Clinical Reference